Genfit S.A. (GNFT)
NASDAQ: GNFT · Real-Time Price · USD
4.050
0.00 (0.00%)
May 14, 2025, 4:00 PM - Market open
Genfit Employees
Genfit had 180 employees as of December 31, 2024. The number of employees increased by 21 or 13.21% compared to the previous year.
Employees
180
Change (1Y)
21
Growth (1Y)
13.21%
Revenue / Employee
$406,598
Profits / Employee
$8,668
Market Cap
210.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GNFT News
- 18 hours ago - GENFIT: Publication of the 2025 Extra-Financial Performance Report (fiscal year 2024) - GlobeNewsWire
- 7 days ago - GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents - GlobeNewsWire
- 10 days ago - GENFIT to Present Latest ACLF Research at EASL Congress 2025 - GlobeNewsWire
- 15 days ago - GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F - GlobeNewsWire
- 16 days ago - GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025 - GlobeNewsWire
- 20 days ago - GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
- 7 weeks ago - GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders - GlobeNewsWire